ImaRx Therapeutics - Urokinase - Ownership and Business Overview

Life ScienceCompany

ImaRx Therapeutics - Urokinase Ownership

Who owns ImaRx Therapeutics - Urokinase?

ImaRx Therapeutics - Urokinase is owned by Microbix Biosystems. It was acquired on September 24, 2008.

ImaRx Therapeutics - Urokinase Business Overview

Where is ImaRx Therapeutics - Urokinase headquartered?

ImaRx Therapeutics - Urokinase is headquartered in United States.

What sector is ImaRx Therapeutics - Urokinase in?

ImaRx Therapeutics - Urokinase is a life science company.

Life Science M&A Summary in 2008

Out of 60 sectors in the Mergr database, life science ranked 10 in number of deals in 2008. The largest life science acquisition in 2008 was Alpharma Pharmaceuticals - which was acquired by King Pharmaceuticals for $16.0B.

Join Mergr to view all 128 acquisitions of life science companies in 2008, including 24 acquisitions by private equity firms, and 104 by strategics.

ImaRx Therapeutics - Urokinase


United States,

ImaRx Therapeutics - Urokinase is a thrombolytic or clot-dissolving agent indicated for the treatment of acute massive pulmonary embolism, or blood clots in the lungs.


 Subscribe to unlock this and 207,502
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for ImaRx Therapeutics - Urokinase

Life Science Companies , United States Companies